The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
DNA polymorphisms at the BCL11A , HBS1L-MYB , and β- globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease
Open accessAbstract
Sickle cell disease (SCD) is a debilitating monogenic blood disorder with a highly variable phenotype characterized by severe pain crises, acute clinical events, and early mortality. Interindividual variation in fetal hemoglobin (HbF) expression is a known and potentially heritable modifier of SCD severity. High HbF levels are correlated with reduced morbidity and mortality. Common single nucleotide polymorphisms (SNPs) at the BCL11A and HBS1L-MYB loci have been implicated previously in HbF level variation in nonanemic European populations. We recently demonstrated an association between a BCL11A SNP and HbF levels in one SCD cohort [Uda M, et al. (2008) Proc Natl Acad Sci USA 105:1620–1625]. Here, we genotyped additional BCL11A SNPs, HBS1L-MYB SNPs, and an SNP upstream of G γ- globin ( HBG2 ; the Xmn I polymorphism), in two independent SCD cohorts: the African American Cooperative Study of Sickle Cell Disease (CSSCD) and an SCD cohort from Brazil. We studied the effect of these SNPs on HbF levels and on a measure of SCD-related morbidity (pain crisis rate). We strongly replicated the association between these SNPs and HbF level variation (in the CSSCD, P values range from 0.04 to 2 × 10 −42 ). Together, common SNPs at the BCL11A , HBS1L-MYB , and β- globin ( HBB ) loci account for >20% of the variation in HbF levels in SCD patients. We also have shown that HbF-associated SNPs associate with pain crisis rate in SCD patients. These results provide a clear example of inherited common sequence variants modifying the severity of a monogenic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PLINK: a tool set for whole-genome association and population-based linkage analyses.
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089
Disease control priorities in developing countries
(2006) · Choice Reviews Online · doi:10.5860/choice.44-0343 · Cited by 3,628
Mortality in sickle cell disease. Life expectancy and risk factors for early death
Platt, O. S., Brambilla, D. J., Rosse, W. F., Milner, P. F., Castro, O., Steinberg, M. H., & Klug, P. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302303 · Cited by 3,320 · cited 4×
“Subsequent analyses in the CSSCD also clarified the natural history and identified predictors of ACS, in which patients suffer from hypoxia and chest pain secondary to sickling in the pulmonary vasculature (3), and mortality (4).”
BackgroundMethodResultInfluentialSequence Variations in PCSK9, Low LDL, and Protection against Coronary Heart Disease
Cohen, J. C., Boerwinkle, E., Mosley, T. H., & Hobbs, H. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054013 · Cited by 3,181
Newly identified loci that influence lipid concentrations and risk of coronary artery disease
Willer, C. J., Sanna, S., Jackson, A. U., Scuteri, A., Bonnycastle, L. L., Clarke, R., Heath, S. C., Timpson, N. J., Najjar, S. S., Stringham, H. M., et al. (2008) · Nature Genetics · doi:10.1038/ng.76 · Cited by 1,585
Self-citationPain in Sickle Cell Disease: Rates and Risk Factors
Platt, O. S., Thorington, B. D., Brambilla, D. J., Milner, P. F., Rosse, W. F., Vichinsky, E., & Kinney, T. R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199107043250103 · Cited by 1,546
Kathiresan, S., Melander, O., Guiducci, C., Surti, A., Burtt, N. P., Rieder, M. J., Cooper, G. M., Roos, C., Voight, B. F., Havulinna, A. S., et al. (2008) · Nature Genetics · doi:10.1038/ng.75 · Cited by 1,386
Pathogenesis and Treatment of Sickle Cell Disease
Bunn, H. F. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709113371107 · Cited by 1,154 · cited 2×
“This has led to a number of important studies to gain a better understanding of the natural history of this disease, such as the CSSCD (5, 6).”
BackgroundGenome-wide association analysis identifies 20 loci that influence adult height
Initiative, D. G., Weedon, M. N., The Wellcome Trust Case Control Consortium, Cambridge GEM Consortium, Lango, H., Lindgren, C. M., Wallace, C., Evans, D. M., Mangino, M., Freathy, R. M., et al. (2008) · Nature Genetics · doi:10.1038/ng.121 · Cited by 826
Castro, O., Brambilla, D., Thorington, B., Reindorf, C., Scott, R., Gillette, P., Vera, J., & Levy, P. (1994) · Blood · doi:10.1182/blood.v84.2.643.643 · Cited by 808
Cited by
Rees, D. C., Williams, T. N., & Gladwin, M. T. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61029-x · Cited by 2,504
Piel, F. B., Steinberg, M. H., & Rees, D. C. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1510865 · Cited by 1,488
Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A
Sankaran, V. G., Menne, T. F., Xu, J., Akie, T. E., Lettre, G., Van Handel, B., Mikkola, H. K. A., Hirschhorn, J. N., Cantor, A. B., & Orkin, S. H. (2008) · Science · doi:10.1126/science.1165409 · Cited by 919
Self-citationCao, A., & Galanello, R. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181cd68ed · Cited by 722
Self-citationValidating therapeutic targets through human genetics
Plenge, R. M., Scolnick, E. M., & Altshuler, D. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4051 · Cited by 712
An Erythroid Enhancer of BCL11A Subject to Genetic Variation Determines Fetal Hemoglobin Level
Bauer, D. E., Kamran, S. C., Lessard, S., Xu, J., Fujiwara, Y., Lin, C., Shao, Z., Canver, M. C., Smith, E. C., Pinello, L., et al. (2013) · Science · doi:10.1126/science.1242088 · Cited by 653
Self-citationPiel, F. B., Steinberg, M., & Rees, D. C. (2016) · Spiral (Imperial College London) · doi:10.1056/nejmc1706325#sa6 · Cited by 659
Fetal hemoglobin in sickle cell anemia
Akinsheye, I., Alsultan, A., Solovieff, N., Ngo, D., Baldwin, C. T., Sebastiani, P., Chui, D. H. K., & Steinberg, M. H. (2011) · Blood · doi:10.1182/blood-2011-03-325258 · Cited by 553
Higgs, D. R., Engel, J. D., & Stamatoyannopoulos, G. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60283-3 · Cited by 434
How I use hydroxyurea to treat young patients with sickle cell anemia
Ware, R. E. (2010) · Blood · doi:10.1182/blood-2009-04-146852 · Cited by 396
Borg, J., Papadopoulos, P., Georgitsi, M., Gutiérrez, L., Grech, G., Fanis, P., Phylactides, M., Verkerk, A. J. M. H., van der Spek, P. J., Scerri, C. A., et al. (2010) · Nature Genetics · doi:10.1038/ng.630 · Cited by 371
Developmental and species-divergent globin switching are driven by BCL11A
Sankaran, V. G., Xu, J., Ragoczy, T., Ippolito, G. C., Walkley, C. R., Maika, S. D., Fujiwara, Y., Ito, M., Groudine, M., Bender, M. A., et al. (2009) · Nature · doi:10.1038/nature08243 · Cited by 379
Self-citationXu, J., Sankaran, V. G., Ni, M., Menne, T. F., Puram, R. V., Kim, W., & Orkin, S. H. (2010) · Genes & Development · doi:10.1101/gad.1897310 · Cited by 361
Self-citationKLF1 regulates BCL11A expression and γ- to β-globin gene switching
Zhou, D., Liu, K., Sun, C.-W., Pawlik, K. M., & Townes, T. M. (2010) · Nature Genetics · doi:10.1038/ng.637 · Cited by 367
Genome-wide association studies: potential next steps on a genetic journey
McCarthy, M. I., & Hirschhorn, J. N. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn289 · Cited by 359
Self-citationThe switch from fetal to adult hemoglobin.
Sankaran, V. G., & Orkin, S. H. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a011643 · Cited by 333
“In addition to the common genetic variants identified in BCL11A associated with HbF levels in humans, the GWAS studies showed that there were variants on chromosome 6 intergenic between the genes HBS1L and MYB that appear to have a dramatic effect on HbF levels in humans (Menzel et al. 2007; Thein et al. 2007; Lettre…”
BackgroundInfluentialSelf-citationCorrection of Sickle Cell Disease in Adult Mice by Interference with Fetal Hemoglobin Silencing
Xu, J., Peng, C., Sankaran, V. G., Shao, Z., Esrick, E. B., Chong, B. G., Ippolito, G. C., Fujiwara, Y., Ebert, B. L., Tucker, P. W., et al. (2011) · Science · doi:10.1126/science.1211053 · Cited by 326
Self-citationGenetic modifiers of sickle cell disease
Steinberg, M. H., & Sebastiani, P. (2012) · American Journal of Hematology · doi:10.1002/ajh.23232 · Cited by 315
The multifunctional role of EKLF/KLF1 during erythropoiesis
Siatecka, M., & Bieker, J. J. (2011) · Blood · doi:10.1182/blood-2011-03-331371 · Cited by 315
Cao, A., & Kan, Y. W. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a011775 · Cited by 289
Self-citationCorvol, H., Blackman, S. M., Boëlle, P.-Y., Gallins, P. J., Pace, R. G., Stonebraker, J. R., Accurso, F. J., Clement, A., Collaco, J. M., Dang, H., et al. (2015) · Nature Communications · doi:10.1038/ncomms9382 · Cited by 278
Family-based designs for genome-wide association studies
Ott, J., Kamatani, Y., & Lathrop, M. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2989 · Cited by 271
Galarneau, G., Palmer, C. D., Sankaran, V. G., Orkin, S. H., Hirschhorn, J. N., & Lettre, G. (2010) · Nature Genetics · doi:10.1038/ng.707 · Cited by 269
Self-citationControl of fetal hemoglobin: new insights emerging from genomics and clinical implications
Thein, S. L., Menzel, S., Lathrop, M., & Garner, C. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp401 · Cited by 250
Bradner, J. E., Mak, R., Tanguturi, S. K., Mazitschek, R., Haggarty, S. J., Ross, K., Chang, C. Y., Bosco, J., West, N., Morse, E., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006774107 · Cited by 211
Reawakening fetal hemoglobin: prospects for new therapies for the β-globin disorders
Bauer, D. E., Kamran, S. C., & Orkin, S. H. (2012) · Blood · doi:10.1182/blood-2012-06-292078 · Cited by 177
Self-citationChang, K.-H., Smith, S. E., Sullivan, T., Chen, K., Zhou, Q., West, J. A., Liu, M., Liu, Y., Vieira, B. F., Sun, C., et al. (2017) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2016.12.009 · Cited by 155
Bauer, D. E., & Orkin, S. H. (2015) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2015.08.001 · Cited by 143
Self-citationWake-up Sleepy Gene: Reactivating Fetal Globin for β-Hemoglobinopathies
Wienert, B., Martyn, G. E., Funnell, A. P. W., Quinlan, K. G. R., & Crossley, M. (2018) · Trends in Genetics · doi:10.1016/j.tig.2018.09.004 · Cited by 115
Recent progress in understanding and manipulating haemoglobin switching for the haemoglobinopathies
Vinjamur, D. S., Bauer, D. E., & Orkin, S. H. (2018) · British Journal of Haematology · doi:10.1111/bjh.15038 · Cited by 114
Self-citationFetal haemoglobin in sickle-cell disease: from genetic epidemiology to new therapeutic strategies
Lettre, G., & Bauer, D. E. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01341-0 · Cited by 104
Self-citationFetal hemoglobin levels and morbidity in untransfused patients with β-thalassemia intermedia.
Musallam, K. M., Sankaran, V. G., Cappellini, M. D., Duca, L., Nathan, D. G., & Taher, A. T. (2012) · Blood · doi:10.1182/blood-2011-09-382408 · Cited by 103
Self-citationAlsultan, A., Alabdulaali, M. K., Griffin, P. J., AlSuliman, A. M., Ghabbour, H. A., Sebastiani, P., Albuali, W. H., Al‐Ali, A. K., Chui, D. H. K., & Steinberg, M. H. (2014) · British Journal of Haematology · doi:10.1111/bjh.12650 · Cited by 95
“…89 4 (Lettre et al, 2008) Reticulocytes % 9 1 6 2 5 8 5 9 7 2 HbF % 15 6 22 17 3 13 3 28 9 < 5 years 21 5 > 15 years (Adekile et al, 2007) 11 4 6 4 (Lettre et al, 2008) a-Thalassaemia 51% n/a n/a 62% 42% (Adekile et al, 2007) 38% 30% (Steinberg & Embury, 1986) G6PD deficiency 28% n/a n/a 21% 2 5%…”
Cell and Gene Therapy for the Beta-Thalassemias: Advances and Prospects
Mansilla-Soto, J., Riviere, I., Boulad, F., & Sadelain, M. (2016) · Human Gene Therapy · doi:10.1089/hum.2016.037 · Cited by 83
Brendel, C., Negre, O., Rothe, M., Guda, S., Parsons, G., Harris, C., McGuinness, M., Abriss, D., Tsytsykova, A., Klatt, D., et al. (2020) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2020.03.015 · Cited by 72
KLF1 directly activates expression of the novel fetal globin repressor ZBTB7A/LRF in erythroid cells
Norton, L. J., Funnell, A. P. W., Burdach, J., Wienert, B., Kurita, R., Nakamura, Y., Philipsen, S., Pearson, R. C. M., Quinlan, K. G. R., & Crossley, M. (2017) · Blood Advances · doi:10.1182/bloodadvances.2016002303 · Cited by 65
Jawaid, K., Wahlberg, K., Thein, S. L., & Best, S. (2010) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2010.05.006 · Cited by 64
Customizing the genome as therapy for the β-hemoglobinopathies.
Canver, M. C., & Orkin, S. H. (2016) · Blood · doi:10.1182/blood-2016-01-678128 · Cited by 61
Self-citationGuo, M. H., Nandakumar, S. K., Ulirsch, J. C., Zekavat, S. M., Buenrostro, J. D., Natarajan, P., Salem, R. M., Chiarle, R., Mitt, M., Kals, M., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1619052114 · Cited by 54
Genetic modifiers of fetal haemoglobin in sickle cell disease
Menzel, S., & Thein, S. L. (2019) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-018-0370-8 · Cited by 50
g(HbF): a genetic model of fetal hemoglobin in sickle cell disease
Gardner, K., Fulford, T., Silver, N., Rooks, H., Angelis, N., Allman, M., Nkya, S., Makani, J., Howard, J., Kesse-Adu, R., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2017009811 · Cited by 43
BCL11A enhancer haplotypes and fetal hemoglobin in sickle cell anemia
Sebastiani, P., Farrell, J. J., Alsultan, A., Wang, S., Edward, H. L., Shappell, H., Bae, H., Milton, J. N., Baldwin, C. T., Al-Rubaish, A. M., et al. (2015) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2015.01.001 · Cited by 41
14q32 and let-7 microRNAs regulate transcriptional networks in fetal and adult human erythroblasts
Lessard, S., Beaudoin, M., Orkin, S. H., Bauer, D. E., & Lettre, G. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy051 · Cited by 38
Self-citationAlsultan, A., Solovieff, N., Aleem, A., AlGahtani, F. H., Al‐Shehri, A., Elfaki Osman, M., Kurban, K., Bahakim, H., Kareem Al‐Momen, A., Baldwin, C. T., et al. (2011) · American Journal of Hematology · doi:10.1002/ajh.22032 · Cited by 32
Variants of ZBTB7A (LRF) and its β-globin gene cluster binding motifs in sickle cell anemia
Shaikho, E. M., Habara, A. H., Alsultan, A., Al-Rubaish, A. M., Al-Muhanna, F., Naserullah, Z., Alsuliman, A., Qutub, H. O., Patra, P. K., Sebastiani, P., et al. (2016) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2016.04.001 · Cited by 20
Vathipadiekal, V., Farrell, J. J., Wang, S., Edward, H. L., Shappell, H., Al‐Rubaish, A. M., Al‐Muhanna, F., Naserullah, Z., Alsuliman, A., Qutub, H. O., et al. (2016) · American Journal of Hematology · doi:10.1002/ajh.24527 · Cited by 20
Al-Ali, Z. A., Fallatah, R. K., Aljaffer, E. A., Albukhari, E. R., Sadek Al-Ali, N., Al-Ghannam, Z. T., Sayeb Al-Atrash, R., Alsuliman, A., & Vatte, C. (2018) · Acta Haematologica · doi:10.1159/000491688 · Cited by 13
Metadata
- Authors
- Lettre, G., Sankaran, V. G., Bezerra, M. A. C., Araújo, A. S., Uda, M., Sanna, S., Cao, A., Schlessinger, D., Costa, F. F., Hirschhorn, J. N., & Orkin, S. H.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2008-08-19
- Volume
- 105
- Issue
- 33
- Pages
- 11869-11874
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2070879341
- Cited by
- 561
- References
- 33
- FWCI
- 15.37
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.